MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis: In this single centre retrospective study, we report the clinical outcomes in 8 patients with de novo or recurrent MPO-ANCA associated vasculitis and severe renal involvement treated with RTX with no CYC association.